| Old Articles: <Older 29331-29340 Newer> |
|---|
 |
The Motley Fool
March 27, 2008
Brian Lawler |
Eli Lilly Hands Over Cold Cash Lilly loses to the state of Alaska in a courtroom battle over its top drug Zyprexa.   |
The Motley Fool
March 27, 2008
Timothy M. Otte |
A Dent in Movado's Distribution The watchmaker is trying to strengthen the image of its brand. |
The Motley Fool
March 27, 2008
Toby Shute |
Upset City: Season Wrap-up Let's look back at last year's underdog choices and see how they fared. |
The Motley Fool
March 27, 2008
Alyce Lomax |
Citi Trends' Markup This discount retail stock's looking awfully pricey. |
The Motley Fool
March 27, 2008
Dave Mock |
The Next Great Telecom Spinoff? Investors eagerly await the next Telmex spinoff, hopeful it will have the same success as America Movil. |
The Motley Fool
March 27, 2008
Brian Lawler |
A Little Bit of Cash for ArQule Development-stage drugmaker ArQule announces that it has received a milestone payment for discovery-stage drug work that it performed for partner Wyeth. |
The Motley Fool
March 27, 2008
Rick Aristotle Munarriz |
Cutting Back at CNET Pink slips are the latest fashion accessory at CNET Networks. The online media company is letting 120 of its employees go in a move to streamline operations while focusing on its leading brands. |
The Motley Fool
March 27, 2008
Brian Lawler |
A Drugmaker's Candid Thoughts on the FDA Cardiome updates investors on its top two drugs. |
The Motley Fool
March 27, 2008
David Lee Smith |
Ford's Saying Tata to Jag and Rover Ford will trim a pair of British brands as it tries to survive. |
The Motley Fool
March 27, 2008
Steven Renaldi |
Conn's: Located for Growth The electronics retailer is concentrated in fast-growing cities, and gives upbeat guidance for the coming year. |
| <Older 29331-29340 Newer> Return to current articles. |
